Explain ataxia in detail, including its types, causes, clinical features, diagnostic work‑up, and management.

Ataxia: Comprehensive Overview

Ataxia is the inability to generate coordinated voluntary movement, manifesting as clumsiness, nystagmus, dysmetria, abnormal gait, dysdiadochokinesis, or dyssynergia, with cerebellar dysfunction being the dominant cause, though disruptions in basal ganglia, cerebral cortex, spinal cord, peripheral nerves, sensory, and vestibular systems can also produce ataxia. 1

Definition and Core Pathophysiology

Ataxia represents incoordination that may occur in isolation or as part of broader neurological conditions 2. The cerebellum is the primary anatomical substrate, but multiple neuronal circuits can be affected 1. Importantly, muscle weakness and hypotonia may mimic ataxia with gait and postural abnormalities, and "pseudoataxia" can occur with functional disorders 1.

Types of Ataxia

Cerebellar Ataxia

• Truncal ataxia specifically indicates cerebellar vermian pathology 1
• Morphologic changes (atrophy) and signal alterations primarily involve the cerebellum and brainstem 3
• Atrophy of the cervical spinal cord has been reported in several forms including SCA1, SCA7, Friedreich ataxia, and ataxia with vitamin E deficiency 3

Sensory (Proprioceptive) Ataxia

• Loss of coordination due to loss of normal position sense, characterized by worsening with closed eyes (positive Romberg test) 3, 1
• Results from neurodegeneration or inflammation involving spinocerebellar tracts, dorsal columns of the spinal cord, dorsal root ganglia, or peripheral sensory nerves 3
• Distinct from cerebellar ataxia in that symptoms worsen when visual input is removed 3

Vestibular Ataxia

• A lurching gait triggered by head rotation is typical of vestibular dysfunction 1

Clinical Features and Localization

Specific Clinical Signs Point to Anatomical Localization:

• Pupillary abnormalities: suggest drug/toxin ingestion versus third cranial nerve compression 1
• Torticollis or resistance to head/neck motion: indicates craniocervical junction pathology, cord compression, or posterior fossa tumor 1
• Motor spasticity with ataxia: suggests spinal cord involvement requiring spine MRI 3

Causes by Temporal Pattern

Acute Ataxia (develops within hours to days, typically <72 hours):

• In children: postinfectious cerebellar ataxia is most common (approximately 50% of emergency department presentations), followed by brain tumors (11.2% of cases) 1
• Etiologies include: infectious, inflammatory, toxic, ischemic, or traumatic causes 1
• Most cases of acute childhood ataxia are transient and benign 1

Chronic Ataxia (lasting >2 months):

• Nonprogressive: suggests congenital brain malformation or early prenatal/perinatal brain injury 1
• Progressive: may be due to inherited causes or acquired posterior fossa lesions causing gradual cerebellar dysfunction 1

Intermittent/Episodic Ataxia:

• May represent migraine, benign positional vertigo, or intermittent metabolic disorders 1

Epidemiology

• Childhood ataxia prevalence: approximately 26 per 100,000 children in European data, though true worldwide prevalence may be higher 1
• Regional variations: higher prevalence of genetic causes in countries with high consanguinity; higher prevalence of infectious causes (malaria, varicella) in endemic regions 1

Diagnostic Work-Up

Clinical Evaluation Framework:

Evaluation requires careful review of demographics, history (especially symptom duration and additional neurological deficits), clinical examination, laboratory testing, and neuroimaging 1

Imaging Approach:

For Cerebellar Ataxia:

• MRI head without IV contrast is the preferred initial imaging modality 3
• Adequately evaluates morphologic changes (atrophy) and signal alterations in cerebellum and brainstem 3
• Add contrast (MRI without and with IV contrast) if concern exists for inflammatory or neoplastic causes 3
• Advanced MRI techniques (DWI/diffusion-tensor imaging, spectroscopy) show promise in detecting early changes and distinguishing ataxia subtypes 3

For Sensory Ataxia:

• MRI cervical and thoracic spine without and with IV contrast when chronic disequilibrium with sensory ataxia is present, particularly if loss of proprioception is out of proportion to other findings 3
• Allows evaluation of spinal cord atrophy reported in SCA1, SCA7, Friedreich ataxia, and vitamin E deficiency 3

For Acute Ataxia in Children:

• CT imaging is helpful when clinical suggestion of acute infectious causes exists 1
• In young children and infants where detailed neurological examination is challenging, initial imaging plays a critical role 1

Genetic Testing Strategy:

Dominant Family History:

• First-line screening: SCA 1,2,3,6,7, and 17 (level B recommendation) 4
• In Asian patients, also screen for dentatorubral-pallidoluysian atrophy (DRPLA) 4

Recessive Disease:

• Stepwise work-up targeting: Friedreich ataxia, ataxia telangiectasia, ataxia due to vitamin E deficiency, POLG gene mutations, ARSACS, and AOA types 1 and 2 4

Sporadic Cases:

• If onset <45 years: perform full work-up for recessive ataxias 4
• If onset >45 years: screen for FMR1 premutations 4
• If onset >30 years in sporadic cases: consider multiple system atrophy 4

Laboratory and Electrodiagnostic Testing:

• Biochemical analyses are essential, particularly for acquired ataxias (autoimmune, toxic, infectious, vitamin deficiency causes) 5
• Electrodiagnostic testing confirms autoimmune sensory ataxic neuropathies 3
• Targeted ultrasound can detect nerve size changes in small studies 3

Management

Disease-Specific Treatments:

Friedreich Ataxia:

• Omaveloxolone was FDA-approved in 2023 as the first drug to treat Friedreich ataxia 2
• Idebenone is NOT effective (level A evidence) 4

Symptomatic Treatments (Regardless of Etiology):

• Riluzole (level B evidence) may provide symptomatic relief 4
• Amantadine (level C evidence) might provide symptomatic relief 4
• Varenicline for SCA3 patients (level B evidence) can be considered 4

Rehabilitation:

• Level Class II evidence supports physiotherapy 4
• Level Class III evidence supports occupational therapy 4
• Intensive physical therapy appears helpful 6

Treatable Causes - Critical Not to Miss:

• Some rare forms of ataxia can be treated, particularly those due to vitamin deficiencies, autoimmune causes, and certain metabolic disorders 5, 6
• Early therapy may prevent progressive cerebellar ataxia in acquired forms 5

Common Pitfalls and Caveats

Diagnostic Pitfalls:

• Do not assume all ataxia is cerebellar - sensory ataxia worsens with eye closure (Romberg test), while cerebellar ataxia does not 3, 1
• Peripheral neuropathy (ataxic neuropathy) can occur in various forms of SCA, but cerebellar symptoms should be present 3
• Lack of IV contrast on MRI may impair ability to distinguish between degenerative and inflammatory/infectious causes 3
• Postictal ataxia in children with epilepsy can be mistaken for primary ataxic disorder 1

Management Considerations:

• Most heredodegenerative ataxias have purely symptomatic treatment 4
• Genetic work-up is evolving with next-generation sequencing, gene panel diagnostics, and whole exome/genome sequencing for selected cases 4
• Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) was identified in 2019 as biallelic intronic repeat expansion in RFC1 gene 2

Prognostic Factors:

• Spinocerebellar ataxia type 27b was recently described as a late-onset hereditary ataxia and appears to be a common form 2
• Brain atrophy staging in SCA3 can enable accurate clinical prognosis and trial enrichment 7
• Atrophy stage is associated with both clinical severity (SARA score) and time from disease onset 7